TET2 Mutations in Ph-Negative-Myeloproliferative Neoplasms: Identification of Three Novel Mutations and Relationship With Clinical and Laboratory Findings

Open Journal of Blood Diseases
doi 10.4236/ojbd.2013.33017
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scientific Research Publishing, Inc.

Related search

DNMT3A Mutations in Myeloproliferative Neoplasms

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Epigenetics and Mutations in Chronic Myeloproliferative Neoplasms

Haematologica
Hematology
2011English

SRSF2 Mutations in Myelodysplasia/Myeloproliferative Neoplasms

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2018English

The Ph-Positive and Ph-Negative Myeloproliferative Neoplasms: Some Topical Pre-Clinical and Clinical Issues

Haematologica
Hematology
2011English

Mutations of ASXL1 Gene in Myeloproliferative Neoplasms

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

JAK2 and MPL Mutations in Myeloproliferative Neoplasms: Discovery and Science

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

MPL W515 L/K Mutations in Myeloproliferative Neoplasms

Egyptian Journal of Medical Human Genetics
Genetics
2019English

Kinase Domain Mutations Confer Resistance to Novel Inhibitors Targeting JAK2V617F in Myeloproliferative Neoplasms

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Frequency of Heterozygous TET2 Deletions in Myeloproliferative Neoplasms

Cancer Management and Research
Oncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy